Second Sight Medical (EYES) IPO Opens Sharply Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
Go back to Second Sight Medical (EYES) IPO Opens Sharply Higher
November 21, 2014 10:25 AM EST
This week's hot IPO for Second Sight Medical (NASDAQ: EYES) is giving some back today. After gaining 162% in it fist two days of trading, shares are down 9.5% to $21.35 today. The IPO priced at $9.
Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients
...
More
November 20, 2014 8:44 AM EST
Second Sight Medical (NASDAQ: EYES) is showing early gains Thursday following the company's strong debut on yesterday's session.
Wednesday, Second Sight opened for trading at $17 after pricing 3.5 million common shares at $9 apiece. Overall, the stock close 122 percent higher to $19.97.
Ahead of the bell, Second Sight is up an additional 15 percent.
...
More
November 19, 2014 12:50 PM EST
While off the highs, traders are getting chatty about today's IPO for Second Sight Medical Products (NASDAQ: EYES) as it is expected to be highlighted on CNBC in a little while. Shares are up 105% at last check to $18.50 after pricing at $9.
...
More
November 19, 2014 7:56 AM EST
Second Sight Medical Products, Inc. (Nasdaq: EYES) announced the pricing of its initial public offering of 3,500,000 shares of common stock, at a price of $9.00 per share. Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. Its current product, the Argus® II System, which treats outer retinal degenerations such as retinitis... More
